U. Gieler, E. Peters, V. Streit, I. Pulido, D. Porombka, A. Jäckel
{"title":"Impact of a Dispenser in Acne Therapy - “PUMP It” Study with 1,388 Patients","authors":"U. Gieler, E. Peters, V. Streit, I. Pulido, D. Porombka, A. Jäckel","doi":"10.29011/2575-8268/100055","DOIUrl":"https://doi.org/10.29011/2575-8268/100055","url":null,"abstract":"Because daily dosage is difficult to achieve in topical acne therapy, a dispenser was developed to ensure the delivery of a pre-measured amount (0.5 mL) of adapalene 0.1% / benzoyl peroxide 2.5% (adapalene-BPO). This non-interventional study assessed application and convenience of a pump dispenser, treatment adherence, efficacy and safety under daily practice conditions. The included patients (≥ 9 years) with moderate to severe acne received adapalene-BPO in the pump. Assessments were carried out at baseline and after 3 to 12 weeks of treatment. Overall, 1,388 patients were enrolled, and facial acne severity improved in 96.9% of patients. Application was described as easy and time-saving and89.6% of patients used the acne gel regularly. Dysmorphic concerns were reported in 5.6% of acne patients. Adapalene-BPO dispensed from the pump is easy to apply, simplifies acne treatment and leads to good treatment adherence in patients with moderate to severe inflammatory acne.","PeriodicalId":320981,"journal":{"name":"Clinical and Experimental Dermatology and Therapies","volume":"19 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134274876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Involvement of PDGF-BB in the Perivascular Localization of Mesenchymal Stem Cells in Human Skin","authors":"T. Soma","doi":"10.29011/2575-8268/100052","DOIUrl":"https://doi.org/10.29011/2575-8268/100052","url":null,"abstract":"Somatic stem cells play crucial roles in homeostasis and regeneration of adult tissues. In contrast to the epidermis, several studies have analyzed the exact nature and localization of stem cells in the human dermis. We aimed to elucidate the effect of Platelet-derived Growth Factor (PDGF)-BB on the perivascular existence of Mesenchymal Stem Cells (MSCs), and to analyze the effect of MSCs on dermal homeostasis. We applied a 3D laser scanning confocal microscope to visualize the sites of PDGFBB deposition. Additionally, we analyzed the interactions between MSCs and the microvasculature in the dermis using several in vitro experimental systems including 3D skin equivalents. PDGF-BB accumulation was apparent in the periendothelial portion of the microvasculature in the dermis. MSC migration and colony formation was stimulated by PDGF-BB. Moreover, a significant increase in PDGFB gene expression was observed upon addition of MSC culture supernatant, whereas there was a drastic decrease in Intercellular Adhesion Molecule 1 (ICAM-1) expression. In addition, the production of the dermal components was enhanced in 3D skin equivalents harboring a tubular-like network induced by MSCs. These results indicate that PDGF-BB functions as a key molecule for the existence of MSCs, resulting in an appropriate interaction with the dermal microvasculature.","PeriodicalId":320981,"journal":{"name":"Clinical and Experimental Dermatology and Therapies","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128518431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Increased Plasma Levels of Programmed Death Ligand 1 in Patients with Primary Sjögren's Syndrome","authors":"Cuiping Liu","doi":"10.29011/2575-8268/100050","DOIUrl":"https://doi.org/10.29011/2575-8268/100050","url":null,"abstract":"To determine the plasma levels of soluble forms of Programmed Death Ligand 1(sPD-L1) in patients with Primary Sjögren’s syndrome (pSS), and determine whether altered circulating sPD-L1 levels correlate with cytokines or clinical manifestations. Plasma levels of sPD-L1 in 64 patients with pSS and 61 healthy controls were examined by enzyme-linked immunosorbent assay (ELISA). Cytokines in plasma were detected using human Th1/Th2/Th17 cytometric bead array (CBA) kit. Data were evaluated for correlations between plasma sPD-L1 levels and clinical features. Levels of sPD-L1 differed significantly between patients and healthy controls (0.7025±0.04645 versus 0.3642±0.01713, P < 0.0001). Plasma sPD-L1 were positively correlated with IgM (r = 0.3898, P = 0.0129), ESR (r = 0.3801, P = 0.0084), RF (r = 0.4163, P = 0.0198), ALT(r= 0.3028, P = 0.0457), AST (r=0.4455,P=0.0028), and the ESSDAI score (r= 0.3866, P = 0.0066). In addition, PD-L1 levels in plasma were correlated significantly with IFN-γ (r = 0.3685, P = 0.0092) and IL-17 (r =0.3436, P = 0.0127). Plasma sPD-L1 levels may increase in patients with pSS and correlate with the severity of disease. PD-1/PD-L1 interaction may contribute to the development of pSS.","PeriodicalId":320981,"journal":{"name":"Clinical and Experimental Dermatology and Therapies","volume":"2 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129944201","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}